| Trial ID: | L0890 |
| Source ID: | NCT02307344
|
| Associated Drug: |
Nigella Sativa
|
| Title: |
Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis (NASH NAFLD)
|
| Acronym: |
NASH NAFLD
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis;Liver Steatosis
|
| Interventions: |
Dietary Supplement: Nigella Sativa;Dietary Supplement: Placebo
|
| Outcome Measures: |
Effect of Nigella Sativa on Liver Triglyceride ConcentrationEffect of Nigella Sativa on Improvement in NASH Activity Index;Effect of Nigella Sativa on Fibrosis Staging
|
| Sponsor/Collaborators: |
Hillel Yaffe Medical Center
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
|
| Start Date: |
03/11/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Israel
|
| URL: |
http://clinicaltrials.gov/show/NCT02307344
|
